NFA
LSTA icon

Nationwide Fund Advisors’s Lisata Therapeutics LSTA Stock Holding History

Nationwide Fund Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-120
Closed -$46K – 3334
2015
Q1 		$46K Hold
120
– – ﹤0.01% 3113
2014
Q4 		$68K Hold
120
– – ﹤0.01% 2986
2014
Q3 		$100K Buy
120
+2
+2% +$1.75K ﹤0.01% 2985
2014
Q2 		$116K Buy
+118
New +$115K ﹤0.01% 2983

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nationwide Fund Advisors's LSTA Position: Q2 2015 in Review

Nationwide Fund Advisors sold out of Lisata Therapeutics (LSTA) in Q2 2015, closing a stake of 120 shares — an estimated $46K sold.

Nationwide Fund Advisors first reported a position in LSTA in Q2 2014 and held it in 4 quarters. The position peaked at $116K in Q2 2014. 51 funds tracked by Wall St. Rank hold LSTA as of Q2 2015.

  • Nationwide Fund Advisors reported no remaining Lisata Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 120 Lisata Therapeutics shares in Q2 2015, an estimated $46K.
  • Nationwide Fund Advisors first reported a position in Lisata Therapeutics in Q2 2014 and held it in 4 quarters.
  • Nationwide Fund Advisors's Lisata Therapeutics position peaked at $116K in Q2 2014.
  • 51 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2015.

Based on Nationwide Fund Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.